Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-21 Purchase |
2021-06-22 5:12 pm |
Verve Therapeutics Inc. | VERV | Casdin Partners Master Fund L.P. 10% Owner |
1,100,000 | $19 | $20,900,000 | 2,417,596 (Direct) |
View |
| 2021-06-21 Purchase |
2021-06-21 6:25 pm |
Verve Therapeutics Inc. | VERV | Beaudoin Margaret Vice President, Finance |
1,000 | $19 | $19,000 | 11,799 (Direct) |
View |
| 2021-06-21 Purchase |
2021-06-21 6:21 pm |
Verve Therapeutics Inc. | VERV | Bellinger Andrew Chief Scientific Officer |
5,000 | $19 | $95,000 | 26,599 (Direct) |
View |
| 2021-06-21 Purchase |
2021-06-21 6:20 pm |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
2,500 | $19 | $47,500 | 622,528 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-21 Conversion |
2021-06-22 5:12 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Casdin Partners Master Fund L.P. 10% Owner |
13,517,885 | $0 | 2,417,596 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 6:25 pm |
N/A 2031-06-16 |
Verve Therapeutics Inc. | VERV | Beaudoin Margaret Vice President, Finance |
10,799 | $0 | 11,799 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 6:21 pm |
N/A 2031-06-16 |
Verve Therapeutics Inc. | VERV | MacLean Michael F Director |
47,664 | $0 | 47,664 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 6:21 pm |
N/A 2031-06-16 |
Verve Therapeutics Inc. | VERV | Bellinger Andrew Chief Scientific Officer |
21,599 | $0 | 26,599 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 6:20 pm |
N/A 2031-06-16 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
53,998 | $0 | 622,528 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 6:18 pm |
N/A 2031-06-16 |
Verve Therapeutics Inc. | VERV | Ashe Andrew D. See Remarks |
21,599 | $0 | 21,599 (Direct) |
View |
Ownership |
2021-06-16 9:11 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Beam Therapeutics Inc. 10% Owner |
0 | $0 | 546,970 (Direct) |
View |
Ownership |
2021-06-16 9:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Redmile Group LLC Green Jeremy 10% Owner |
0 | $0 | 886,530 (Indirect) |
View |
Ownership |
2021-06-16 8:07 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Biomatics Capital Partners L.P. 10% Owner |
0 | $0 | 2,597,464 (Direct) |
View |
Ownership |
2021-06-16 7:42 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Joung Jae Keith 10% Owner |
0 | $0 | 409,625 (Indirect) |
View |
Ownership |
2021-06-16 7:42 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer 10% Owner |
0 | $0 | 2,293,983 (Direct) |
View |
Ownership |
2021-06-16 7:40 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
0 | $0 | 10,793,414 (Indirect) |
View |
Ownership |
2021-06-16 7:38 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Rozen Israel 10% Owner |
0 | $0 | 409,626 (Direct) |
View |
Ownership |
2021-06-16 7:38 pm |
N/A 2031-03-31 |
Verve Therapeutics Inc. | VERV | Mikhail Sheila Director |
0 | $0 | 43,198 (Direct) |
View |
Ownership |
2021-06-16 7:37 pm |
N/A 2031-03-31 |
Verve Therapeutics Inc. | VERV | Evans John M. Director |
0 | $0 | 43,198 (Direct) |
View |
Ownership |
2021-06-16 7:35 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners X LLC CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 2,508,809 (Indirect) |
View |
Ownership |
2021-06-16 7:34 pm |
N/A 2031-02-11 |
Verve Therapeutics Inc. | VERV | Bellinger Andrew Chief Scientific Officer |
0 | $0 | 550,783 (Direct) |
View |
Ownership |
2021-06-16 7:33 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | ADELMAN BURT A Director 10% Owner |
0 | $0 | 452,824 (Indirect) |
View |
Ownership |
2021-06-16 7:31 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | GV 2017 GP L.L.C. GV 2017 GP L.P. GV 2017 L.P. 10% Owner |
0 | $0 | 6,320,905 (Indirect) |
View |
Ownership |
2021-06-16 7:31 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Ticho Barry 10% Owner |
0 | $0 | 409,626 (Direct) |
View |
Ownership |
2021-06-16 7:29 pm |
N/A 2031-02-11 |
Verve Therapeutics Inc. | VERV | Beaudoin Margaret Vice President, Finance |
0 | $0 | 64,797 (Direct) |
View |
Ownership |
2021-06-16 7:28 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. 10% Owner |
0 | $0 | 4,472,509 (Indirect) |
View |
Ownership |
2021-06-16 7:27 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Casdin Partners Master Fund L.P. 10% Owner |
0 | $0 | 1,317,596 (Direct) |
View |
Ownership |
2021-06-16 7:23 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Ashe Andrew D. See Remarks |
0 | $0 | 550,783 (Direct) |
View |
Ownership |
2021-06-16 7:22 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Casdin Private Growth Equity Fund L.P. 10% Owner |
0 | $0 | 620,571 (Direct) |
View |
Ownership |
2021-06-16 7:20 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Logos Global Management LP 10% Owner |
0 | $0 | 443,265 (Indirect) |
View |
Ownership |
2021-06-16 7:18 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
0 | $0 | 2,495,571 (Direct) |
View |
Ownership |
2021-06-16 7:18 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Broad Institute Inc. 10% Owner |
0 | $0 | 421,954 (Direct) |
View |
Ownership |
2021-06-16 7:15 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner |
0 | $0 | 709,224 (Indirect) |
View |
Ownership |
2021-06-16 5:33 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | FMR LLC See Remark 1 10% Owner |
0 | $0 | 1,037,294 (Indirect) |
View |
Ownership |
2021-06-16 5:18 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Novo Holdings A/S 10% Owner |
0 | $0 | 443,265 (Direct) |
View |
Ownership |
2021-06-16 4:55 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner |
0 | $0 | 709,224 (Indirect) |
View |